Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Hepatorenal Syndrome Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Hepatorenal Syndrome 31
Jul 13, 2017: Mallinckrodt Phase 3 Terlipressin Trial Achieves its Enrollment Target Ahead of Schedule 31
Jun 23, 2017: Health Economic Data on Burden of Hepatorenal Syndrome Published in Current Medical Research and Opinion 31
Clinical Trial Profile Snapshots 33
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Source 57
List of Tables
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Region, 2017* 6
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Hepatorenal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
Hepatorenal Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Hepatorenal Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Hepatorenal Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Hepatorenal Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 15
Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 18
Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Hepatorenal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
List of Figures
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Hepatorenal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
Hepatorenal Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Hepatorenal Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 15
Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 18
Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Hepatorenal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 56
